Gadoev Jamshid, Asadov Damin, Harries Anthony D, Parpieva Nargiza, Tayler-Smith Katie, Isaakidis Petros, Ali Engy, Hinderaker Sven Gudmund, Ogtay Gozalov, Ramsay Andrew, Jalolov Avazbek, Dara Masoud
World Health Organization country office in Uzbekistan, Tashkent, Uzbekistan.
State Post Graduate Institute of Medical Education, Tashkent, Uzbekistan.
PLoS One. 2017 May 4;12(5):e0176473. doi: 10.1371/journal.pone.0176473. eCollection 2017.
In Uzbekistan, despite stable and relatively high tuberculosis treatment success rates, relatively high rates of recurrent tuberculosis have recently been reported. Recurrent tuberculosis is when a patient who was treated for pulmonary tuberculosis and cured, later develops the disease again. This requires closer analysis to identify possible causes and recommend interventions to improve the situation. Using countrywide data, this study aimed to analyse trends in recurrent tuberculosis cases and describe their associations with socio-demographic and clinical factors.
Countrywide retrospective cohort study comparing recurrent tuberculosis patients with all new tuberculosis patients registered within the NTP between January 2006 and December 2010 using routinely collected data. Determinants studied were baseline characteristics and treatment outcomes.
Of 107,380 registered patients during the period January 2006 and December 2010, 9358 (8.7%) were recurrent cases. Between 2006 and 2008, the number of recurrent cases per annum increased from 1530 to 2081, then fell slightly thereafter from 2081 to 1888 cases. The proportion of all notified cases during this period increased from 6.5% to 9.9%. Factors associated with recurrent tuberculosis included age (35-55 years old), having smear positive pulmonary tuberculosis, residing in certain areas of Uzbekistan, having particular co-morbidities (including chronic obstructive pulmonary disease and HIV), and being unemployed, a pensioner or disabled. Recurrent tuberculosis patients also had a higher likelihood of having an unfavourable treatment outcome.
Despite signs of declining national tuberculosis notifications between 2006 and 2010, the relative proportion of recurrent cases appears to have increased. These findings, together with the identification of possible risk factors associated with recurrent tuberculosis, highlight various areas where Uzbekistan needs to focus its tuberculosis control efforts, particularly in light of the country's rapidly emerging multi drug resistant tuberculosis epidemic.
在乌兹别克斯坦,尽管结核病治疗成功率稳定且相对较高,但最近有报告称复发性结核病发病率相对较高。复发性结核病是指曾接受过肺结核治疗并已治愈的患者,后来再次患上该病。这需要进行更深入的分析,以确定可能的原因并推荐改善这种情况的干预措施。本研究利用全国范围的数据,旨在分析复发性结核病例的趋势,并描述其与社会人口统计学和临床因素的关联。
采用全国范围的回顾性队列研究,利用常规收集的数据,将复发性结核病患者与2006年1月至2010年12月期间在国家结核病规划中登记的所有新结核病患者进行比较。所研究的决定因素为基线特征和治疗结果。
在2006年1月至2010年12月期间登记的107380名患者中,9358例(8.7%)为复发病例。2006年至2008年期间,每年复发病例数从1530例增加到2081例,此后略有下降,从2081例降至1888例。在此期间,所有通报病例的比例从6.5%增加到9.9%。与复发性结核病相关的因素包括年龄(35至55岁)、痰涂片阳性的肺结核、居住在乌兹别克斯坦的某些地区、患有特定的合并症(包括慢性阻塞性肺疾病和艾滋病毒),以及失业、领取养老金或残疾。复发性结核病患者出现不良治疗结果的可能性也更高。
尽管2006年至2010年期间全国结核病通报有下降迹象,但复发病例的相对比例似乎有所增加。这些发现以及与复发性结核病相关的可能风险因素的确定,凸显了乌兹别克斯坦在结核病控制工作中需要重点关注的各个领域,特别是鉴于该国迅速出现的多重耐药结核病疫情。